久久久久国产精品aⅴ天堂,成人性生交A片免费直播APP ,男女扒开双腿猛进入爽爽免费,日本JAPANESE少妇高清

China Ginkgolide injection - China Supplier
China Ginkgolide injection - China Supplier

Ginkgolide injection

Price:Negotiable
Industry Category: Chemicals/Pharmaceutical/Cardiovascular-agent
Product Category:
Brand: BAIYU
Spec:


Contact Info
  • Add:10th Floor, Building B7, Tianfu Life Science Park, Life Science Park, South Keyuan Road, Wuhou District, Chengdu, P.R.China, Zip: 610000
  • Contact: Sylvia Lei
  • Tel:+86-028-83379750-8011
  • Email:sales@baiyu.cn

Other Products

Description
Additional Information

Active ingredients: bilobalide, ginkgolide A, ginkgolide B and ginkgolide C.

Description: a colorless or pale-yellow clear liquid.

Dosage Form: liquid injection.
Indications: For mild to moderate cerebral infarction, symptoms are hemiplegia, deviated tongue, paralalia and paraesthesia, etc.
Strength: 2ml/ampoule, containing 10mg ginkgolide.

Storage: Keep airtight in a dark and cool place.

Packaging: ampoule, 5 ampoules/box (Can be customized based on customer's order.)

Shelf Life: 24months.
Dosage and Administration:
Administrated by intravenous infusion. The recommended dose is 5 bottles (10ml). Before use, add the powder into 250ml of 0.9% sodium chloride injection or 250ml of 5% glucose injection for dilution and administrated as a slow intravenous infusion. Give the dosage once a day; during the infusion, strictly control the rate ranging from 40 to 60 drops per minute. The course of treatment is 14 days.
Contradictions:
1. Patients with a history of hypersensitivity or adverse reaction to the product or any other finished ginkgo products.
2. Patients with a history of hypersensitivity to ethanol, glycerin, ethanol (alcohol) and glycerol.
3. Contradicted in pregnant and lactating women.
Pharmacology and toxicology:
The results of non-clinical pharmacodynamic study showed that the product can reduce the stroke score, the mortality rate and the cerebral infarction area in the rat  focal cerebral ischemia model using the suture method; can promote the recovery of  amplitude of EEG potential, can reduce cerebral ** content in the gerbil cerebral ischemia-reperfusion model; can reduce brain wet weight, brain index, cerebral ** content in the rat cerebral ischemia-reperfusion model using 4-vessel occlusion method, reduce the damage of hippocampal CA1 (increase the density of neuron in the region).

 

CDMO Service Undertaking

Dosage Form

Production Lines

Annual Capacity 

Injection

8

650,000,000

Oral Solid

3

700,000,000

API & Intermediates

3

8,000 Kg

TCM Extraction

2

5,000,000 Kg 

Baiyu provide CDMO service for:

  FDFs & APIs

  Primary & secondary packaging

  Warehousing

  Commercial scale, pilot scale, laboratory scale

You are warmly welcomed to contact us for business cooperation.

sales@baiyu.cn

Chengdu Baiyu Pharmaceutical Co., Ltd.

Industry Category Chemicals/Pharmaceutical/Cardiovascular-agent
Product Category
Brand: BAIYU
Spec:
Stock:
Origin:
About Toocle.com - Partner Programme - Old Version
Copyright ? Toocle.com. All Rights Reserved.
(浙)-經營性-2023-0192
主站蜘蛛池模板: 开原市| 托里县| 衡水市| 银川市| 内乡县| 彭水| 白城市| 德州市| 左贡县| 乐亭县| 灌云县| 晴隆县| 临夏市| 长沙县| 林芝县| 乌拉特后旗| 邯郸县| 张家港市| 蕉岭县| 西安市| 久治县| 临武县| 汝城县| 阿坝县| 班戈县| 兰西县| 宜章县| 张北县| 甘肃省| 大竹县| 绥阳县| 宾阳县| 襄汾县| 乐至县| 鄂尔多斯市| 长武县| 固安县| 乐昌市| 上高县| 宜章县| 当雄县|